Chemists at Scripps Research in La Jolla say they have pulled off a bold molecular renovation of fentanyl, carving out its ...

BioDuro has appointed Andrew Thomas (top left) and Stevan Djuric (top right) as Scientific Advisors. Thomas was formerly ...

A new study published in the journal of Current Medicinal Chemistry revealed an elevated Atherogenic Index of Plasma (AIP) independently predicts major adverse cardiovascular events ...

Industry leaders bring decades of pharmaceutical R&D leadership to support BioDuro’s global innovation and clients’ programs  IRVINE, Calif., - March 12, 2026 — BioDuro, a leading global contract ...

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Genentech has elected to stop a phase 2 trial of a RIPK1 inhibitor early and dump the asset after an analysis revealed the candidate was unlikely to meet the study’s primary endpoint. | Genentech has ...

A new “magic mushroom” compound may deliver psychedelic brain benefits without the trip.

An MSU-led team found promising therapeutics for two diseases that currently lack effective treatment, demonstrating how gene ...

Synnovation will receive total cash consideration of up to $3 billion, consisting of $2 billion in upfront cash and up to $1 ...

Ten UMSL students presented diverse research projects to legislators during Undergraduate Research Day at the Missouri Capitol in Jefferson City on March 12.

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...